MJBizDaily
The federal hemp ban will create a pet-safety problem – and no one is talking about it
Featured
Latest Posts
Nevada lawsuit
Pennsylvania’s medical marijuana dispensaries sold more than $500 million in MMJ products since sales began two years ago, a state official said Wednesday.
News November 13Proposed law in North Macedonia to allow cannabis flower export shelved
A North Macedonian draft bill that proposed modifications to the current medical cannabis framework has been removed from parliament’s agenda, according to Telma Television. The bill would have created a legal…
News November 13California Marijuana Notebook: Emerald Triangle growers show confidence in market health but prep for challenges ahead
After a turbulent transition into a legal market in 2018, marijuana cultivators and other cannabis companies in California's famed Emerald Triangle are finally finding their footing and are optimistic about…
News November 13Massachusetts keeps cannabis vape ban, orders quarantine of products as regulators focus on suspect additive
Massachusetts regulators maintained a ban on the sale of cannabis oil vaporizers and devices after ordering marijuana retailers to quarantine the products on Tuesday, dealing a financial blow to MJ companies hoping…
News November 12Canadian, overseas medical cannabis sales drive Tilray’s revenue higher
British Columbia-based cannabis producer Tilray reported third-quarter revenue of $51.1 million (CA$67.8 million), a 408% jump from the same period a year earlier. Tilray also booked an 11% improvement from…
News November 12Cannabis comp tables – now with EV/EBITDA – as of Nov. 11, 2019
This comp table provides a benchmark for private investors to evaluate existing and future investments as well as a menu for public investors to peruse.
News November 12Canadian cannabis firms rapped over ‘deficient’ corporate governance disclosures
Canada’s securities watchdog is warning the nation’s cannabis businesses of “deficient” corporate governance disclosures and urging them to address concerns related to potential conflicts of interest. The Canadian Securities Administrators…
News November 12New UK guidelines recommend public insurance coverage for two GW Pharma cannabis medicines, plus a synthetic cannabinoid
New British guidelines for the first time recommend that two plant-based cannabis medicines – Sativex and Epidiolex – be covered through the United Kingdom’s National Health Service (NHS), a significant…
News November 12












